Bristol Myers Squibb has appointed Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, effective immediately. Gallman succeeds Sandra Leung, who has chosen to retire after a 33-year career at the company. Gallman, an accomplished leader with extensive experience in pharmaceutical law and compliance, will lead the law department as well as global and U.S. policy and government affairs. She has held leadership positions at Bristol Myers Squibb for 10 years. “C...